Tagworks Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Private

  • Employees
  • 46

Employees

  • Latest Deal Type
  • Series A

  • Latest Deal Amount
  • $70.7M

  • Investors
  • 12

Tagworks General Information

Description

Developer of antibody-based imaging and therapy technology designed to improve the efficacy of cancer therapies. The company's technology enables the actuation of tagged antibodies through selective chemical manipulation in vivo, improving the efficacy of established approaches such as radioimmuno-imaging and therapy and antibody-drug conjugates, enabling doctors to effectively imaging at markedly lower radiation doses to patients.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Toernooiveld 1
  • 6525 ED Nijmegen
  • Netherlands
+31 085
Primary Industry
Drug Delivery
Other Industries
Pharmaceuticals
Biotechnology
Vertical(s)
Corporate Office
  • Toernooiveld 1
  • 6525 ED Nijmegen
  • Netherlands
+31 085

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Tagworks Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Later Stage VC (Series A) 01-Jun-2023 $70.7M Completed Pre-Clinical Trials
4. Later Stage VC 27-Nov-2021 Completed Pre-Clinical Trials
3. Grant 31-Dec-2015 Completed Pre-Clinical Trials
2. Grant 18-Dec-2015 $969K Completed Pre-Clinical Trials
1. Grant 16-Dec-2013 Completed Pre-Clinical Trials
To view Tagworks’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Tagworks Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Developer of antibody-based imaging and therapy technology designed to improve the efficacy of cancer therapies. The com
Drug Delivery
Nijmegen, Netherlands
46 As of 2025

Belfast, United Kingdom
 

Macclesfield, United Kingdom
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Tagworks Competitors (2)

One of Tagworks’s 2 competitors is CV6 Therapeutics, a Venture Capital-Backed company based in Belfast, United Kingdom.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
CV6 Therapeutics Venture Capital-Backed Belfast, United Kingdom
Redx Pharma Venture Capital-Backed Macclesfield, United Kingdom
You’re viewing 2 of 2 competitors. Get the full list »

Tagworks Patents

Tagworks Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026229500-A1 Pyrrolobenzodiazepines with click-cleavable protection Pending 29-Apr-2025
WO-2026215290-A1 Trans-cyclooctene combinations and uses thereof Pending 07-Apr-2025
EP-4777155-A1 Trans-cyclooctene formulations Pending 22-Aug-2024
WO-2026043376-A1 Trans-cyclooctene formulations Pending 22-Aug-2024
WO-2025174248-A1 Trans-cyclooctenes with "or gate" release Pending 16-Feb-2024 A61K47/68031
To view Tagworks’s complete patent history, request access »

Tagworks Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Tagworks Investors (12)

Investor Name Investor Type Holding Investor Since Participating Rounds
Gilde Healthcare PE/Buyout Minority
Lightstone Ventures Venture Capital Minority
New Enterprise Associates Venture Capital Minority
Novartis Venture Fund Corporate Venture Capital Minority
Ysios Capital Venture Capital Minority
You’re viewing 5 of 12 investors. Get the full list »

Tagworks FAQs

  • When was Tagworks founded?

    Tagworks was founded in 2011.

  • Where is Tagworks headquartered?

    Tagworks is headquartered in Nijmegen, Netherlands.

  • What is the size of Tagworks?

    Tagworks has 46 total employees.

  • What industry is Tagworks in?

    Tagworks’s primary industry is Drug Delivery.

  • Is Tagworks a private or public company?

    Tagworks is a Private company.

  • What is Tagworks’s current revenue?

    The current revenue for Tagworks is .

  • How much funding has Tagworks raised over time?

    Tagworks has raised $70.7M.

  • Who are Tagworks’s investors?

    Gilde Healthcare, Lightstone Ventures, New Enterprise Associates, Novartis Venture Fund, and Ysios Capital are 5 of 12 investors who have invested in Tagworks.

  • Who are Tagworks’s competitors?

    CV6 Therapeutics and Redx Pharma are competitors of Tagworks.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process